{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:26:21Z","timestamp":1794723981290,"version":"4.9.1"},"reference-count":55,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"unspecified","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,10,30]]},"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Haemophilia is a rare inherited bleeding disorder with complex support and costly treatment. Comprehensive care for people with haemophilia (PwH) must take place in structured and continuously evaluated treatment centres. The aim of the\n                      <jats:italic>Public Assistance for People with Haemophilia in Brazil<\/jats:italic>\n                      Project (PATCH Project) is to assess the infrastructure, human resources and healthcare delivery processes of Brazilian Blood Centres (BC) involved in the provision of haemophilia care.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a nationwide cross-sectional study involving 98 BC across Brazil\u2019s 26 states and the Federal District, focusing on the care provided to PwH. A self-administered structured questionnaire was prepared, based on national and international recommendations for management, treatment and outcomes assessment in PwH. The criteria of the World Federation of Haemophilia and the European Association for Haemophilia and Allied Disorders will be used to define standards of quality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval for this study was granted by the Human Research Ethics Committee of the Federal University of Goi\u00e1s, the coordinating centre (protocol CAAE 53863221.8.0000.5078), and subsequently by all participating institutions. Written informed consent is obtained from all participants prior to enrolment. Study findings will be disseminated through publication in peer-reviewed journals and presentation at international scientific conferences. Research data will be managed in accordance with ethical and legal standards and will be made available on reasonable request to support future investigations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Protocol registration<\/jats:title>\n                    <jats:p>Not applicable<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-111031","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T14:40:43Z","timestamp":1763736043000},"page":"e111031","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Public health assistance for people with haemophilia in Brazil (PATCH study): a cross-sectional study protocol"],"prefix":"10.1136","volume":"15","author":[{"given":"Maria do Ros\u00e1rio Ferraz","family":"Roberti","sequence":"first","affiliation":[{"name":"Federal University of Goi\u00e1s, Faculty of Medicine, Goi\u00e2nia, GO, Brazil"},{"name":"Hemolabor Hematologia e Laborat\u00f3rio, Setor Hematologia, Goi\u00e2nia, GO, Brazil"},{"name":"Department of Health, Government of Goi\u00e1s, Goi\u00e2nia, GO, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin Ricarda e Azevedo","family":"G\u00e9a","sequence":"additional","affiliation":[{"name":"Federal University of Goi\u00e1s, Faculty of Medicine, Goi\u00e2nia, GO, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isadora Almeida","family":"Marinho","sequence":"additional","affiliation":[{"name":"Federal University of Goi\u00e1s, Faculty of Medicine, Goi\u00e2nia, GO, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pollyana Pinheiro","family":"In\u00e1cio","sequence":"additional","affiliation":[{"name":"Hemolabor Hematologia e Laborat\u00f3rio, Setor Hematologia, Goi\u00e2nia, GO, Brazil"},{"name":"Federal University of Goi\u00e1s, Intitute of Tropical Pathology and Public Health, Postgraduate Program in Public Health, Goi\u00e2nia, GO, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Mesquita","family":"Camelo","sequence":"additional","affiliation":[{"name":"Federal University of Minas Gerais, Faculty of Medicine, Belo Horizonte, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Figueiredo","family":"de Castro","sequence":"additional","affiliation":[{"name":"University of Brasilia, Faculty of Medicine, Bras\u00edlia, DF, Brazil"},{"name":"University of Brasilia, Postgraduate Program in Public Health, Brasilia, DF, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7356-522X","authenticated-orcid":false,"given":"Sandro Rog\u00e9rio Rodrigues","family":"Batista","sequence":"additional","affiliation":[{"name":"Federal University of Goi\u00e1s, Faculty of Medicine, Goi\u00e2nia, GO, Brazil"},{"name":"Federal University of Goi\u00e1s, Intitute of Tropical Pathology and Public Health, Postgraduate Program in Public Health, Goi\u00e2nia, GO, Brazil"},{"name":"University of Bras\u00edlia, Faculty of Medicine, Postgraduate Program in Medical Sciences, Bras\u00edlia, DF, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"2026111421174458000_15.11.e111031.1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/hematolrep15010014","article-title":"Haemophilia A: A Review of Clinical Manifestations, Treatment, Mutations, and the Development of Inhibitors","volume":"15","author":"Sarmiento Doncel","year":"2023","journal-title":"Hematol Rep"},{"key":"2026111421174458000_15.11.e111031.2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-021-00278-x","article-title":"Haemophilia","volume":"7","author":"Berntorp","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2026111421174458000_15.11.e111031.3","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.221093"},{"key":"2026111421174458000_15.11.e111031.4","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12672"},{"key":"2026111421174458000_15.11.e111031.5","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15444"},{"key":"2026111421174458000_15.11.e111031.6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/hae.13449","article-title":"Joint disease in haemophilia: Pathophysiology, pain and imaging","volume":"24 Suppl 6","author":"van Vulpen","year":"2018","journal-title":"Haemophilia"},{"key":"2026111421174458000_15.11.e111031.7","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/jth.12317","article-title":"Hemophilia A and hemophilia B: focus on arthropathy and variables affecting bleeding severity and prophylaxis","volume":"11","author":"Escobar","year":"2013","journal-title":"J Thromb Haemost"},{"key":"2026111421174458000_15.11.e111031.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067659"},{"key":"2026111421174458000_15.11.e111031.9","unstructured":"World Federation of Hemophilia . Report on the annual global survey 2023. Available from; 2024. Available: www.wfh.org [Accessed 5 Aug 2025]."},{"key":"2026111421174458000_15.11.e111031.10","unstructured":"Minist\u00e9rio da Sa\u00fade . Secretaria de aten\u00e7\u00e3o especializada \u00e0 sa\u00fade. departamento de aten\u00e7\u00e3o especializada em tem\u00e1tica. In: Coordena\u00e7\u00e3o-Geral de Sangue e Hemoderivados. Sistematiza\u00e7\u00e3o: Dados coagulopatias heredit\u00e1rias 2023. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade, 2023."},{"key":"2026111421174458000_15.11.e111031.11","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-023-02690-w","article-title":"The impact of bleeding event frequency on health-related quality of life and work productivity outcomes in a European cohort of adults with haemophilia A: insights from the CHESS II study","volume":"18","author":"Young","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"2026111421174458000_15.11.e111031.12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/hae.14926","article-title":"The psychosocial impact of haemophilia from patients\u2019 and caregivers\u2019 point of view: The results of an Italian survey","volume":"30","author":"Fornari","year":"2024","journal-title":"Haemophilia"},{"key":"2026111421174458000_15.11.e111031.13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/hae.14676","article-title":"Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia: A review of the literature","volume":"29","author":"Iorio","year":"2023","journal-title":"Haemophilia"},{"key":"2026111421174458000_15.11.e111031.14","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1016\/S2352-3026(24)00223-0","article-title":"Risk of harm to people with haemophilia from the 2023 WHO Essential Medicines List","volume":"11","author":"Pierce","year":"2024","journal-title":"Lancet Haematol"},{"key":"2026111421174458000_15.11.e111031.15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jtha.2022.12.029","article-title":"Hemophilia treatment innovation: 50 years of progress and more to come","volume":"21","author":"Mannucci","year":"2023","journal-title":"J Thromb Haemost"},{"key":"2026111421174458000_15.11.e111031.16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia, 3rd edition","volume":"26 Suppl 6","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"2026111421174458000_15.11.e111031.17","doi-asserted-by":"publisher","DOI":"10.1097\/mbc.0000000000000885"},{"key":"2026111421174458000_15.11.e111031.18","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-020-01511-8","article-title":"European principles of inhibitor management in patients with haemophilia: implications of new treatment options","volume":"15","author":"Hermans","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"2026111421174458000_15.11.e111031.19","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102308","article-title":"The Evolution of Hemophilia Therapeutics: An Illustrated Review","volume":"8","author":"Espa\u00f1ol","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"2026111421174458000_15.11.e111031.20","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/17474086.2024.2402304","article-title":"Emicizumab and unmet needs of patients with hemophilia a who are managed with replacement therapies","volume":"17","author":"Mahlangu","year":"2024","journal-title":"Expert Rev Hematol"},{"key":"2026111421174458000_15.11.e111031.21","article-title":"Haemophilia-unparalleled progress but inadequate access","volume":"10","year":"2023","journal-title":"Lancet Haematol"},{"key":"2026111421174458000_15.11.e111031.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-021-07447-4","article-title":"The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis","volume":"22","author":"Soto","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"2026111421174458000_15.11.e111031.23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/17474086.2020.1716726","article-title":"The cost of hemophilia treatment: the importance of minimizing it without detriment to its quality","volume":"13","author":"Rodriguez-Merchan","year":"2020","journal-title":"Expert Rev Hematol"},{"key":"2026111421174458000_15.11.e111031.24","first-page":"316","article-title":"Health care resource utilization and costs among adult patients with hemophilia A on factor VIII prophylaxis: an administrative claims analysis","volume":"27","author":"Croteau","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"key":"2026111421174458000_15.11.e111031.25","first-page":"S123","article-title":"Hemophilia in the managed care setting","volume":"21","author":"Dalton","year":"2015","journal-title":"Am J Manag Care"},{"key":"2026111421174458000_15.11.e111031.26","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-024-11850-y","article-title":"Distribution and predictors of haemophilia-related costs in the United Kingdom: analysis of the CHESS I and CHESS II burden of illness studies","volume":"24","author":"Woollacott","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"2026111421174458000_15.11.e111031.27","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-023-06552-3","article-title":"Estimating the impact of improved management of haemophilia a on clinical outcomes and healthcare utilisation and costs","volume":"16","author":"Chandrasekaran","year":"2023","journal-title":"BMC Res Notes"},{"key":"2026111421174458000_15.11.e111031.28","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/MBC.0000000000000984","article-title":"General concepts on hemophilia A and on women carrying the disease","volume":"31","author":"Mingot Castellano","year":"2020","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2026111421174458000_15.11.e111031.29","doi-asserted-by":"crossref","unstructured":"Hakimi Z , Ghelani R , Bystrick\u00e1 L , et al . Patient Experience of Living With Hemophilia A: A Conceptual Model of Humanistic and Symptomatic Experience in Adolescents, Adults, and Children. JHEOR 2024;95\u2013102. doi:10.36469\/jheor.2024.123374","DOI":"10.36469\/jheor.2024.123374"},{"key":"2026111421174458000_15.11.e111031.30","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13206235","article-title":"Mapping the Patient Experience in a Pediatric Hemophilia Unit: Our Patient Journey","volume":"13","author":"Berrueco","year":"2024","journal-title":"J Clin Med"},{"key":"2026111421174458000_15.11.e111031.31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/hae.13000","article-title":"Care models in the management of haemophilia: a systematic review","volume":"22 Suppl 3","author":"Yeung","year":"2016","journal-title":"Haemophilia"},{"key":"2026111421174458000_15.11.e111031.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01625.x"},{"key":"2026111421174458000_15.11.e111031.33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/hae.13008","article-title":"NHF\u2010McMaster Guideline on Care Models for Haemophilia Management","volume":"22","author":"Pai","year":"2016","journal-title":"Haemophilia"},{"key":"2026111421174458000_15.11.e111031.34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/hae.13010","article-title":"Integrated multidisciplinary care for the management of chronic conditions in adults: an overview of reviews and an example of using indirect evidence to inform clinical practice recommendations in the field of rare diseases","volume":"22 Suppl 3","author":"Yeung","year":"2016","journal-title":"Haemophilia"},{"key":"2026111421174458000_15.11.e111031.35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(19)31243-7","article-title":"Brazil\u2019s unified health system: the first 30 years and prospects for the future","volume":"394","author":"Castro","year":"2019","journal-title":"The Lancet"},{"key":"2026111421174458000_15.11.e111031.36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/bloodadvances.2019GS121559","article-title":"Building the National Program of Inherited Bleeding Disorders in Brazil","volume":"3","author":"Rezende","year":"2019","journal-title":"Blood Adv"},{"key":"2026111421174458000_15.11.e111031.37","doi-asserted-by":"crossref","unstructured":"Souza M , ed. Planejamento e gest\u00e3o em sa\u00fade: caminhos para o fortalecimento das hemorredes . In: EDUFBA. 2018. Available: http:\/\/books.scielo.org\/id\/c8vkc","DOI":"10.7476\/9788523220273"},{"key":"2026111421174458000_15.11.e111031.38","unstructured":"Ag\u00eancia nacional de vigil\u00e2ncia sanit\u00e1ria . In: Resolu\u00e7\u00e3o RDC n\u00b0 151, de 21 de agosto de 2001. Aprova o Regulamento T\u00e9cnico sobre N\u00edveis de Complexidade dos Servi\u00e7os de Hemoterapia. Di\u00e1rio Oficial da Uni\u00e3o, Se\u00e7\u00e3o 1. Bras\u00edlia (DF), 2001."},{"key":"2026111421174458000_15.11.e111031.39","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.htct.2023.12.004","article-title":"Epidemiology, patient journey and unmet needs related to hemophilia in Brazil: a scoping review with evidence map","volume":"46","author":"Schneider","year":"2024","journal-title":"Hematology, Transfusion and Cell Therapy"},{"key":"2026111421174458000_15.11.e111031.40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.21115\/JBES.v9.n3.p249-59","article-title":"Custo-efetividade do fator VII ativado recombinante (rFVIIa) e complexo protromb\u00ednico parcialmente ativado (CCPa) no tratamento sob demanda do sangramento leve\/moderado de pacientes com hemofilia cong\u00eanita complicada por inibidores sob a perspectiva","volume":"9","author":"Pepe","year":"2017","journal-title":"JBES"},{"key":"2026111421174458000_15.11.e111031.41","doi-asserted-by":"crossref","DOI":"10.1016\/j.htct.2025.103736","article-title":"Annualized bleeding rate in hemophilia A patients in Brazil: a systematic review","volume":"47","author":"Prezotti","year":"2025","journal-title":"Hematol Transfus Cell Ther"},{"key":"2026111421174458000_15.11.e111031.42","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1590\/S1414-32832009000500028","article-title":"Princ\u00edpios do Sistema \u00danico de Sa\u00fade (SUS) e a humaniza\u00e7\u00e3o das pr\u00e1ticas de sa\u00fade","volume":"13","author":"Mattos","year":"2009","journal-title":"Interface (Botucatu)"},{"key":"2026111421174458000_15.11.e111031.43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2516.2002.00638.x","article-title":"Haemophilia in the developing world: the Brazilian experience","volume":"8","author":"Antunes","year":"2002","journal-title":"Haemophilia"},{"key":"2026111421174458000_15.11.e111031.44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/JBM.S68234","article-title":"Hemophilia A in Brazil - epidemiology and treatment developments","volume":"5","author":"Ferreira","year":"2014","journal-title":"J Blood Med"},{"key":"2026111421174458000_15.11.e111031.45","doi-asserted-by":"crossref","DOI":"10.1186\/s13561-024-00539-x","article-title":"Cost of hemophilia A in Brazil: a microcosting study","volume":"14","author":"da Silva Etges","year":"2024","journal-title":"Health Econ Rev"},{"key":"2026111421174458000_15.11.e111031.46","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12695","article-title":"Impact of novel hemophilia therapies around the world","volume":"6","author":"Ozelo","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"2026111421174458000_15.11.e111031.47","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.242735"},{"key":"2026111421174458000_15.11.e111031.48","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/hae.14379","article-title":"European principles of care for women and girls with inherited bleeding disorders","volume":"27","author":"van Galen","year":"2021","journal-title":"Haemophilia"},{"key":"2026111421174458000_15.11.e111031.49","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/hae.13830","article-title":"Patient-centred care in haemophilia: Patient perspectives on visualization and participation in decision-making","volume":"25","author":"van Balen","year":"2019","journal-title":"Haemophilia"},{"key":"2026111421174458000_15.11.e111031.50","unstructured":"Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade . Minist\u00e9rio da Sa\u00fade, Bras\u00edlia; Departamento de Aten\u00e7\u00e3o Especializada e Tem\u00e1tica. Manual de hemofilia, 2015. Available: https:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/manual_hemofilia_2ed.pdf [Accessed 5 Aug 2025]."},{"key":"2026111421174458000_15.11.e111031.51","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(21)00132-0","article-title":"The case for equitable haemophilia care","volume":"8","author":"Srivastava","year":"2021","journal-title":"Lancet Haematol"},{"key":"2026111421174458000_15.11.e111031.52","doi-asserted-by":"crossref","first-page":"e395","DOI":"10.1111\/hae.13607","article-title":"Haemophilia care in Latin America: Assessment and perspectives","volume":"24","author":"Boadas","year":"2018","journal-title":"Haemophilia"},{"key":"2026111421174458000_15.11.e111031.53","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.biologicals.2011.03.002","article-title":"The Wildbad Kreuth initiative: European current practices and recommendations for optimal use of blood components","volume":"39","author":"Berger","year":"2011","journal-title":"Biologicals"},{"key":"2026111421174458000_15.11.e111031.54","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11154443","article-title":"Defining the Impact of Social Drivers on Health Outcomes for People with Inherited Bleeding Disorders","volume":"11","author":"Lopez","year":"2022","journal-title":"J Clin Med"},{"key":"2026111421174458000_15.11.e111031.55","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/hae.12429","article-title":"Haemophilia care - beyond the treatment guidelines","volume":"20 Suppl 4","author":"Srivastava","year":"2014","journal-title":"Haemophilia"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-111031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T05:20:54Z","timestamp":1794720054000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-111031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":55,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,21]]},"published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1136\/bmjopen-2025-111031"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-111031","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2025-111031.supp1","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2025-111031.supp2","asserted-by":"subject"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}